Paul J. Clancy, Executive VP and CFO at BIOGEN IDEC INC. (BIIB), sold 23,612 shares at $219.71 ($5.3M) on 2013-04-29, disclosed to the SEC on 2013-05-01.
Scheduled sale ($5.3M) by Executive VP and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $219.71 | 9,123 | $2.0M | 38.1% |
| 2 | $222.57 | 1,968 | $438K | 8.3% |
| 3 | $224.34 | 5,380 | $1.2M | 22.9% |
| 4 | $225.40 | 6,241 | $1.4M | 26.7% |
| 5 | $226.01 | 900 | $203K | 3.9% |
| Total | $222.75 avg | 23,612 |
| $5.3M |
| 100% |
| Filing → |
| ALXN | SELL | 2018-02-08 | $1.4M | — | Filing → |
| BIIB | SELL | 2017-04-27 | $2.9M | — | Filing → |
| BIIB | SELL | 2017-03-14 | $5.8M | — | Filing → |